Episode one of a two-part series on clinical trials and the value of participation

Before a new medical test, drug, procedure, or device can be made safely available to the public, it needs to be studied through what is called a clinical trial. What is a clinical trial, and why is the medical community encouraging people of all walks of life to consider participation in a trial? Is it safe to get involved? These are some of the many questions we’ll address in a two-part series with health care experts and a patient who will talk about her experience as a clinical trial participant.

Joining our show today to the help us understand what a clinical trial is, what’s involved, and the importance to medical advancement are:

Christina Brennan, MD, vice president of clinical research at the Feinstein Institutes for Medical Research. She is also immediate past president of the NY Chapter of the Association of Clinical Research Professionals.

Kenneth Getz, professor and deputy director of Tufts Center for the Study of Drug Development at Tufts University School of Medicine and founder and board chair of the Center for Information and Study on Clinical Research Participation, an organization dedicated to educating and informing about clinical research. Mr. Getz is an internationally renowned expert in R&D and clinical trial management practices.

Resources:

AWARE for All-Long Island

Center for Information and Study on Clinical Research Participation